Company Profile

Aestus Therapeutics Inc
Profile last edited on: 6/17/21      CAGE: 4FM90      UEI:

Business Identifier: Treatment of neuropathic pain
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

104 Windsor Center Drive
East Windsor, NJ 08520
   (732) 249-0690
Location: Single
Congr. District: 12
County: Mercer

Public Profile

Aestus Therapeutics Inc iws establsihed as a private translational medicine company originally organized around treatment of disorders of the nervous system: neuropathic pain. Aestus’ core technology utilized a unique and proprietary set of processes for mining the vast amount of public genomic and pharmaceutical data to generate novel associations between biological targets and diseases to form the basis for new therapeutic approaches. The firmappers to have discontinued operations some time during 2014

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 2 NIH $2,488,925
Project Title: Accelerated Discovery and Development of New Pain Therapeutics

Key People / Management

  Tage Honore -- President

  Lillian W Chiang -- co-founder

  F Aaron Dubberley -- Director of Intellectual Properties

  Daniel J Lavery -- Director of Research and Genomics

  Lisa McCormick -- Media Contact